lactic acid has been researched along with ly2605541 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beals, JM; Cherrington, AD; Jacober, SJ; Michael, MD; Moore, MC; Sinha, VP; Smith, MS | 1 |
1 other study(ies) available for lactic acid and ly2605541
| Article | Year |
|---|---|
Novel PEGylated basal insulin LY2605541 has a preferential hepatic effect on glucose metabolism.
Topics: Animals; Blood Glucose; Dogs; Glucose; Humans; Hypoglycemic Agents; Insulin Lispro; Insulins; Lactic Acid; Liver; Polyethylene Glycols | 2014 |